Dry chemical test card and preparation method thereof

The dry chemical test card integrates hemoglobin, alanine aminotransferase, and triglyceride detection layers to facilitate simultaneous testing with one sample, addressing the inefficiencies of separate testing methods, ensuring accuracy and simplicity for blood donation sites.

CN119064601APending Publication Date: 2024-12-03SHENZHEN DEXIA DIAGNOSTIC TECH CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411200444.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing blood donation sites lack efficient, accurate, and convenient methods for simultaneously testing hemoglobin, alanine aminotransferase, and triglycerides due to cumbersome operations and the need for separate sampling and liquid reagents that require low-temperature storage, which are not suitable for sites with limited resources.

Method used

A dry chemical test card with integrated layers for hemoglobin, alanine aminotransferase, and triglyceride detection, including a card shell with specific holes, color development layers, auxiliary layers, and a blood filtering layer, allowing for simultaneous testing with one sample and preventing cross-talk between reactions.

Benefits of technology

Enables rapid, accurate, and efficient detection of hemoglobin, alanine aminotransferase, and triglycerides with a single test card, reducing operational complexity, cost, and waste, and allowing for bedside diagnosis without the need for professional personnel or specialized equipment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119064601A_ABST
    Figure CN119064601A_ABST
Patent Text Reader

Abstract

The invention discloses a dry chemical test card and a preparation method thereof.The dry chemical test card comprises a card shell, a developing layer, an auxiliary layer, a blood filtering layer and a diffusion layer, a sample adding hole is formed in the top face of the card shell, and a protein detection hole, an isolation detection hole, an enzyme detection hole and an ester detection hole are formed in the bottom face of the card shell; the color developing layer comprises a hemoglobin color developing layer, an isolating layer, an alanine aminotransferase color developing layer and a triglyceride color developing layer which are arranged in the horizontal direction; the auxiliary layer comprises an alanine aminotransferase auxiliary layer and a triglyceride auxiliary layer which are arranged in the horizontal direction, the alanine aminotransferase auxiliary layer is arranged above the alanine aminotransferase color developing layer, and the triglyceride auxiliary layer is arranged above the triglyceride color developing layer; the blood filtering layer is arranged above the auxiliary layer and covers the alanine aminotransferase auxiliary layer and the triglyceride auxiliary layer; the diffusion layer is arranged above the blood filtering layer and covers the blood filtering layer and the hemoglobin developing layer. According to the invention, hemoglobin, alanine aminotransferase and triglyceride can be rapidly determined at the same time, and the detection efficiency is high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biochemical detection, and in particular to a dry chemical test card and a preparation method thereof. Background Art

[0002] Hemoglobin (Hb) is a protein present in red blood cells that can bind to oxygen and transport oxygen. It is one of the important indicators in routine blood tests. It not only reflects the body's ability to produce red blood cells, but can also be used to assist in the diagnosis of some blood diseases. Hemoglobin (Hb) testing is the first test to screen the blood of blood donors before routine blood donation. It is an important indicator that reflects whether the blood donor has related anemia. There are two main reasons for the importance of testing Hb before blood donation: to ensure blood quality and to protect the health of blood donors.

[0003] Alanine aminotransferase (ALT) is mainly present in various cells. Alanine aminotransferase is a routine detection indicator for liver disease. In order to prevent the occurrence of transfusion-transmitted viral hepatitis, before the popularization of specific viral diagnostic reagents, ALT detection is still a routine and important item for blood screening of blood donors at home and abroad. ALT is a sensitive detection indicator recommended by the World Health Organization for detecting liver function damage. Since my country is a high-incidence area of ​​hepatitis, ALT is also one of the main items for blood testing of voluntary blood donors. ALT is widely distributed and can be detected in all tissues of the body, especially in the liver. Under normal circumstances, the content of ALT in serum is very low. When liver cells are damaged, the concentration of serum ALT will increase. Among them, 1% of liver cells are necrotic and the enzyme activity in serum increases by 1 times. In addition, when the permeability of liver cells increases, transaminases can also be released from liver cells, increasing the enzyme content in serum. Therefore, when there is mild or moderate liver damage, due to factors such as liver cell necrosis and increased permeability of liver cell membranes. ALT in the cytoplasm of hepatocytes is released into the blood, resulting in elevated ALT in the blood. The concentration level of ALT in serum is of great significance for the diagnosis and treatment of various types of hepatitis, liver cancer, and cirrhosis.

[0004] Mild to moderate increases in triglycerides (TG) often reflect an increase in very low-density lipoproteins and their remnants (very low-density lipoproteins with smaller particles). These remnant lipoproteins may have a direct atherogenic effect due to their smaller particles. However, most studies suggest that increased TG is likely to have an atherogenic effect by affecting the structure of low-density lipoproteins or high-density lipoproteins. Increased triglycerides are closely related to the risk of atherosclerotic cardiovascular disease, and early detection and treatment of hypertriglyceridemia should be emphasized.

[0005] Blood donation sites usually do not have laboratory testing conditions, and commonly used blood analyzers and biochemical analyzers are not easy to operate on site. Some sites far from the testing laboratory are also not convenient for sending samples for testing. Therefore, blood donation sites often use the easy-to-operate POCT method for testing.

[0006] The existing detection method is to detect hemoglobin, alanine aminotransferase, and triglycerides separately. Among them, hemoglobin detection includes copper sulfate specific gravity method, dry chemical hemoglobin single detection, etc., alanine aminotransferase detection includes transmission colorimetry, dry chemical alanine aminotransferase single detection, etc., and triglyceride detection includes transmission colorimetry, dry chemical lipoprotein esterase single detection, etc. The copper sulfate specific gravity method is a qualitative method with the problem of insufficient accuracy. In addition, the copper sulfate standard solution needs to be manually prepared and calibrated, and its preparation and storage links will affect the performance. It has been gradually replaced by other detection methods. The hemoglobin dry chemical single detection method, the alanine aminotransferase dry chemical single detection method, and the blood lipid dry chemical method are currently the more commonly used methods, but the separate detection requires repeated sampling of peripheral blood, and the operation is relatively cumbersome. The alanine aminotransferase and triglyceride transmission colorimetry methods are liquid reagents and need to be transported and stored under low temperature conditions. It is not convenient for blood donation sites with relatively limited conditions, and there is also the problem of separate detection from hemoglobin. The dry chemical single test method for alanine aminotransferase is currently the more commonly used method, which also has the problem of separate testing from hemoglobin. Summary of the invention

[0007] The present invention aims to solve one of the technical problems in the related art at least to a certain extent. To this end, the purpose of the present invention is to provide a dry chemical test card and a preparation method thereof.

[0008] To achieve the above object, on the one hand, a dry chemical test card according to an embodiment of the present invention includes:

[0009] A card shell, wherein the top surface of the card shell is provided with a sample loading hole, and the bottom surface of the card shell is provided with a protein detection hole, an isolation detection hole, an enzyme detection hole and an ester detection hole;

[0010] A color development layer is provided in the card shell, wherein the color development layer includes a hemoglobin color development layer, an isolation layer, an alanine aminotransferase color development layer and a triglyceride color development layer arranged in a horizontal direction, wherein the hemoglobin color development layer is in contact with the isolation layer, and the isolation layer and the alanine aminotransferase color development layer and the triglyceride color development layer are arranged at intervals from each other; the protein detection hole, the isolation detection hole, the enzyme detection hole and the ester detection hole correspond to the hemoglobin color development layer, the isolation layer, the alanine aminotransferase color development layer and the triglyceride color development layer one by one;

[0011] An auxiliary layer is arranged in the card shell, the auxiliary layer includes an alanine aminotransferase auxiliary layer and a triglyceride auxiliary layer arranged in a horizontal direction, the alanine aminotransferase auxiliary layer is arranged above the alanine aminotransferase color development layer, and the triglyceride auxiliary layer is arranged above the triglyceride color development layer;

[0012] A blood filtering layer is arranged in the card shell, the blood filtering layer is arranged above the auxiliary layer and covers the alanine aminotransferase auxiliary layer and the triglyceride auxiliary layer;

[0013] A diffusion layer is arranged in the cartridge, the diffusion layer is arranged above the blood filter layer and covers the blood filter layer and the hemoglobin color development layer, and is used for diffusing the blood sample added to the sample adding hole to the blood filter layer and the hemoglobin color development layer;

[0014] Among them, the hemoglobin color development layer is pre-set with hemolytic substances and hemoglobin reactants; the alanine aminotransferase color development layer is pre-set with alanine aminotransferase color development reactants, and the alanine aminotransferase auxiliary layer is pre-set with alanine aminotransferase reaction substrates; the triglyceride color development layer is pre-set with triglyceride color development reactants; the isolation layer is used to absorb excess blood sample to prevent the blood sample from diffusing into the alanine aminotransferase color development layer and the triglyceride color development layer.

[0015] In addition, the dry chemical test card according to the above embodiment of the present invention may also have the following additional technical features:

[0016] According to one embodiment of the present invention, the cartridge is formed into a strip structure, and the hemoglobin color development layer, the isolation layer, the alanine aminotransferase color development layer and the triglyceride color development layer are sequentially arranged along the length direction of the cartridge;

[0017] One end of the hemoglobin color development layer adjacent to the isolation layer and one end of the blood filtering layer adjacent to the isolation layer jointly cover the isolation layer.

[0018] According to one embodiment of the present invention, it also includes a supporting layer, which is located in the card shell, and the color development layer is arranged on the supporting layer; there are four through holes on the supporting layer, and the four through holes correspond to the protein detection hole, the isolation detection hole, the enzyme detection hole and the ester detection hole one by one.

[0019] According to one embodiment of the present invention, the isolation layer comprises an isolation upper layer and an isolation lower layer, the isolation upper layer is a blank mixed cellulose membrane, and the isolation lower layer is a blank microporous nylon membrane.

[0020] According to one embodiment of the present invention, the hemoglobin color development layer is a microporous nylon membrane pre-set with hemolytic substances and hemoglobin reactants;

[0021] The alanine aminotransferase color development layer is a microporous nylon membrane pre-set with an alanine aminotransferase color development reactant, and the alanine aminotransferase auxiliary layer is a mixed cellulose membrane pre-set with an alanine aminotransferase reaction substrate;

[0022] The triglyceride color development layer is a microporous nylon membrane pre-set with a triglyceride color development reactant, and the triglyceride auxiliary layer is a blank mixed cellulose membrane.

[0023] The blood filter layer is glass fiber pre-loaded with inorganic salts and sugar components;

[0024] The diffusion layer is a hydrophilic textile mesh, and the support layer is a hard bottom plate.

[0025] According to one embodiment of the present invention, the amount of the hemolytic substance added is 5 to 40 g / L, and the amount of the hemoglobin reactant added is 1 to 30 g / L;

[0026] The hemolytic substance includes a surfactant, and the hemoglobin reactant is a substance that can combine with hemoglobin to form a derivative with stable light absorption characteristics. The hemoglobin reactant is selected from one or more of potassium cyanide, potassium ferrocyanide, sodium azide, sodium nitrite, alkali hydroxyl, and sodium dodecyl sulfate.

[0027] According to one embodiment of the present invention, the alanine aminotransferase reaction substrate includes: 8-80 g / L L-alanine and 1-30 g / L α-ketoglutarate;

[0028] The alanine aminotransferase color development reactant comprises 5-50 g / L phosphate, 300-3000 u / L pyruvate oxidase, 800-8000 u / L catalase and 0.3-30 g / L color developer.

[0029] According to one embodiment of the present invention, the triglyceride color development reactant includes 5-50 g / L phosphate, 800-80000 u / L lipoprotein lipase, 800-50000 u / L glycerol kinase, 800-50000 u / L glycerol-3-phosphate oxidase, 800-8000 u / L catalase and 0.3-30 g / L color developer.

[0030] According to one embodiment of the present invention, the addition amount of the inorganic salt is 2-20 g / L, the addition amount of the carbohydrate component is 10-100 g / L, the inorganic salt is selected from one or more of sodium chloride, potassium chloride, and sodium sulfate, and the carbohydrate component is selected from one or more of glucose, sucrose, lactose, and trehalose.

[0031] On the other hand, a method for preparing a dry chemical test card according to an embodiment of the present invention comprises the following steps:

[0032] 1) Solution preparation: preparing a hemoglobin reactant solution, an alanine aminotransferase reaction substrate solution, an alanine aminotransferase colorimetric reactant solution, a triglyceride colorimetric reactant solution, and a blood filter layer treatment solution;

[0033] 2) Membrane material immersion: The cut microporous nylon membrane is immersed in the prepared hemoglobin reactant solution, alanine aminotransferase colorimetric reactant solution and triglyceride colorimetric reaction solution respectively, and then placed in an environment of 32 to 38° C. for drying after standing for 5 to 15 minutes to obtain a hemoglobin colorimetric layer, an alanine aminotransferase colorimetric layer and a triglyceride colorimetric layer;

[0034] The cut mixed cellulose membrane is placed in the prepared alanine aminotransferase reaction substrate solution, and after standing for 5 to 15 minutes, it is placed in an environment of 32 to 38° C. and dried to obtain an alanine aminotransferase auxiliary layer; the cut glass fiber membrane is placed in the prepared blood filter layer treatment solution, and after standing for 5 to 15 minutes, it is placed in an environment of 32 to 38° C. and dried to obtain a blood filter layer;

[0035] 3) Assembly: sequentially attach the isolation lower layer, alanine aminotransferase colorimetric layer, and triglyceride colorimetric layer to the support layer with the adhesive tape; stack the alanine aminotransferase auxiliary layer on the alanine aminotransferase colorimetric layer, stack the triglyceride auxiliary layer on the triglyceride colorimetric layer, and stack the isolation upper layer on the isolation lower layer; attach the hemoglobin colorimetric layer to the support layer and extend it to cover the isolation upper layer; stack the blood filter layer on the isolation upper layer, the alanine aminotransferase auxiliary layer, and the triglyceride auxiliary layer, stack the diffusion layer on the blood filter layer, and the diffusion layer covers the hemoglobin colorimetric layer; load the stacked layer structure into a card shell to form a dry chemical test card.

[0036] According to one embodiment of the present invention, preparing a hemoglobin reaction solution, an alanine aminotransferase reaction substrate solution, an alanine aminotransferase color reaction solution, a triglyceride color reaction solution, and a blood filter layer treatment solution comprises:

[0037] Dissolve 1-30 g / L of sodium dodecyl sulfate and 4-40 g / L of potassium ferrocyanide in deionized water, and stir evenly to obtain a hemoglobin reactant solution;

[0038] Dissolve 8 to 80 g / L of L-alanine and 1 to 30 g / L of α-ketoglutaric acid in deionized water, stir evenly, and obtain an alanine aminotransferase reaction substrate solution;

[0039] Dissolve 5-50 g / L of phosphate, 300-3000 u / L of pyruvate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain an alanine aminotransferase color reaction solution;

[0040] Dissolve 5-50 g / L of phosphate, 800-80000 u / L of lipoprotein lipase, 800-50000 u / L of glycerol kinase, 800-50000 u / L of glycerol-3-phosphate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain a triglyceride color development reaction solution;

[0041] Dissolve 2-20 g / L of sodium chloride and 10-25 g / L of sucrose in deionized water, stir evenly, and obtain a blood filter layer treatment solution.

[0042] According to one embodiment of the present invention, preparing a hemoglobin reaction solution, an alanine aminotransferase reaction substrate solution, an alanine aminotransferase color development reaction solution, and a blood filter layer treatment solution comprises:

[0043] Dissolve 5-40 g / L of sodium deoxycholate and 1-30 g / L of sodium nitrite in deionized water, stir evenly, and obtain a hemoglobin reaction solution;

[0044] Dissolve 8 to 80 g / L of L-alanine and 1 to 30 g / L of α-ketoglutaric acid in deionized water, stir evenly, and obtain an alanine aminotransferase reaction substrate solution;

[0045] Dissolve 5-50 g / L of phosphate, 300-3000 u / L of pyruvate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain an alanine aminotransferase color reaction solution;

[0046] Dissolve 2-20 g / L of sodium sulfate and 10-25 g / L of sucrose in deionized water, stir evenly, and obtain a blood filter layer treatment solution.

[0047] The dry chemical test card and preparation method thereof provided by the embodiment of the present invention are used to determine the content of hemoglobin, alanine aminotransferase, and triglyceride in human blood samples, and realize that hemoglobin, alanine aminotransferase, and triglyceride can be quickly determined simultaneously with one test card and one peripheral blood sampling and adding. Each test item is independent of each other and does not interfere with each other, thereby improving the detection efficiency. The test card has the advantages of simple operation, low cost, no need for professional personnel to operate, no waste liquid treatment requirements, and rapid diagnosis during the detection process. It is equipped with a small detection instrument and can be moved at any time without being restricted by time and place. It can truly realize bedside diagnosis and is suitable for first aid, emergency, home, pharmacy, community hospital, outpatient clinic, physical examination center and other places.

[0048] Additional aspects and advantages of the present invention will be given in part in the following description and in part will be obvious from the following description, or will be learned through practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the structures shown in these drawings without paying creative work.

[0050] Figure 1 It is a schematic diagram of the structure of a dry chemical test card according to an embodiment of the present invention.

[0051] Reference numerals:

[0052] 10. Stuck;

[0053] 101, upper shell;

[0054] 102, lower shell;

[0055] H101, protein detection well;

[0056] H102, isolation detection hole;

[0057] H103, enzyme detection well;

[0058] H104, ester detection hole;

[0059] H105, sample well;

[0060] 20. Hemoglobin color development layer;

[0061] 21. Isolation layer;

[0062] 211, Isolate the upper layer;

[0063] 212, isolate the lower layer;

[0064] 22. Alanine aminotransferase colorimetric layer;

[0065] 23. Alanine aminotransferase auxiliary layer;

[0066] 24. Triglyceride color layer;

[0067] 25. triglyceride auxiliary layer;

[0068] 26. Blood filter layer;

[0069] 27. Diffusion layer;

[0070] 28. Support layer;

[0071] H28, through hole.

[0072] The realization of the purpose, functional features and advantages of the present invention will be further explained in conjunction with embodiments and with reference to the accompanying drawings. DETAILED DESCRIPTION

[0073] The embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, but are not to be construed as limiting the present invention. All other embodiments obtained by ordinary technicians in the field without creative work based on the embodiments of the present invention are within the scope of protection of the present invention.

[0074] In the description of the present invention, it is to be understood that the terms “center”, “longitudinal”, “lateral”, “length”, “width”, “thickness”, “up”, “down”, “front”, “back”, “left”, “right”, “vertical”, “horizontal”, “top”, “bottom”, “inside”, “outside”, “clockwise”, “counterclockwise”, “axial”, “circumferential”, “radial”, etc., indicating orientations or positional relationships based on the orientations or positional relationships shown in the accompanying drawings, are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as limiting the present invention.

[0075] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.

[0076] In the present invention, unless otherwise clearly specified and limited, a first feature being "above" or "below" a second feature may include that the first and second features are in direct contact, or may include that the first and second features are not in direct contact but are in contact through another feature between them. Moreover, a first feature being "above", "above" and "above" a second feature includes that the first feature is directly above and obliquely above the second feature, or simply indicates that the first feature is higher in level than the second feature. A first feature being "below", "below" and "below" a second feature includes that the first feature is directly below and obliquely below the second feature, or simply indicates that the first feature is lower in level than the second feature.

[0077] The dry chemical test card and the preparation method thereof according to the embodiment of the present invention are described in detail below with reference to the accompanying drawings.

[0078] Reference Figure 1 As shown, the dry chemical test card provided according to the embodiment of the present invention is used to simultaneously detect hemoglobin, alanine aminotransferase and triglycerides in a blood sample. The test card comprises a card shell 10, a color development layer, an auxiliary layer, a blood filter layer 26 and a diffusion layer 27.

[0079] Specifically, the top surface of the card shell 10 is provided with a sample addition hole H105, and the sample addition hole H105 is used to add a blood sample, for example, the collected peripheral blood is dripped into the sample addition hole H105 to achieve the addition of the blood sample. The bottom surface of the card shell 10 is provided with a protein detection hole H101, an isolation detection hole H102, an enzyme detection hole H103 and an ester detection hole H104. Exemplarily, the card shell 10 may include an upper shell 101 and a lower shell 102, and the upper shell 101 and the lower shell 102 are mutually buckled. The card shell 10 of this structure is convenient for the assembly of the test card. In application, the test card is inserted into the jack of the detector, and the detector has a photoelectric detection module at the position corresponding to each detection hole, and the photoelectric detection module is used to perform sample detection on the blood sample in each detection hole.

[0080] The color development layer includes a hemoglobin color development layer 20, an isolation layer 21, an alanine aminotransferase color development layer 22, and a triglyceride color development layer 24 arranged in a horizontal direction, wherein the hemoglobin color development layer 20 is in contact with the isolation layer 21, and the isolation layer 21 and the alanine aminotransferase color development layer 22 and the triglyceride color development layer 24 are arranged at intervals from each other. The protein detection hole H101, the isolation detection hole H102, the enzyme detection hole H103, and the ester detection hole H104 correspond to the hemoglobin color development layer 20, the isolation layer 21, the alanine aminotransferase color development layer 22, and the triglyceride color development layer 24 one by one. That is, the hemoglobin color development layer 20 is opposite to the protein detection hole H101 in the upper and lower directions, the isolation layer 21 is opposite to the isolation detection hole H102 in the upper and lower directions, the alanine aminotransferase color development layer 22 is opposite to the enzyme detection hole H103 in the upper and lower directions, and the triglyceride color development layer 24 is opposite to the ester detection hole H104 in the upper and lower directions. In short, each detection hole corresponds to a detection area.

[0081] The auxiliary layer includes an alanine aminotransferase auxiliary layer 23 and a triglyceride auxiliary layer 25 arranged in a horizontal direction. The alanine aminotransferase auxiliary layer 23 is disposed above the alanine aminotransferase color development layer 22 , and the triglyceride auxiliary layer 25 is disposed above the triglyceride color development layer 24 .

[0082] The blood filter layer 26 is disposed above the auxiliary layer and covers the alanine aminotransferase auxiliary layer 23 and the triglyceride auxiliary layer 25 .

[0083] The diffusion layer 27 is disposed above the blood filtering layer 26 and covers the blood filtering layer 26 and the hemoglobin color development layer 20 , so as to diffuse the blood sample added to the sample adding hole H105 to the blood filtering layer 26 and the hemoglobin color development layer 20 .

[0084] Among them, the hemoglobin color development layer 20 is pre-installed with hemolytic substances and hemoglobin reactants; the alanine aminotransferase color development layer 22 is pre-installed with alanine aminotransferase color development reactants, and the alanine aminotransferase auxiliary layer 23 is pre-installed with alanine aminotransferase reaction substrates; the triglyceride color development layer 24 is pre-installed with triglyceride color development reactants; the isolation layer 21 is used to absorb excess blood sample to prevent the blood sample from diffusing into the alanine aminotransferase color development layer 22 and the triglyceride color development layer 24.

[0085] The test card is usually sealed and refrigerated. When testing is needed, take out the test card, add the blood sample to the sample adding hole H105, and then insert the test card into the jack of the detector. On the one hand, part of the blood sample will diffuse to the surroundings under the action of the expansion layer. On the one hand, the blood sample diffuses to the hemoglobin color development layer 20, and the hemoglobin is dissolved and released under the action of the hemolytic substance, and then a color reaction occurs with the hemoglobin reactant.

[0086] On the other hand, after another part of the blood sample passes through the blood filtering layer 26, the red blood cells are filtered out, and the remaining plasma diffuses to the alanine aminotransferase auxiliary layer 23 and the triglyceride auxiliary layer 25 respectively. At the position of the enzyme detection hole H103, the alanine aminotransferase in the plasma reacts with the reaction substrate pre-immersed in the alanine aminotransferase auxiliary layer 23, and the generated reactant further diffuses to the alanine aminotransferase color development layer 22, and reacts with the color development reactant therein. Similarly, at the position of the ester detection hole H104, the triglyceride in the plasma will also react with the color development reactant in the triglyceride color development layer 24. Finally, the photoelectric detection module under each detection hole is used for detection, and the specific content values ​​of hemoglobin, alanine aminotransferase and triglyceride are automatically calculated by the processor.

[0087] During this process, the excess blood is absorbed by the isolation layer 21, thereby effectively isolating each detection area and preventing crosstalk between different reaction substances. At the same time, the isolation layer 21 and the alanine aminotransferase color development layer 22 and the triglyceride color development layer 24 are arranged at intervals from each other. It is also possible to prevent the reaction substances between the various detection areas from crosstalking with each other, ensuring that each detection area can be detected independently and ensuring the accuracy of the detection results.

[0088] The dry chemical test card and preparation method thereof provided by the embodiment of the present invention are used to determine the content of hemoglobin, alanine aminotransferase, and triglyceride in human blood samples, and realize that hemoglobin, alanine aminotransferase, and triglyceride can be quickly determined simultaneously with one test card and one peripheral blood sampling and adding. Each test item is independent of each other and does not interfere with each other, thereby improving the detection efficiency. The test card has the advantages of simple operation, low cost, no need for professional personnel to operate, no waste liquid treatment requirements, and rapid diagnosis during the detection process. It is equipped with a small detection instrument and can be moved at any time without being restricted by time and place. It can truly realize bedside diagnosis and is suitable for first aid, emergency, home, pharmacy, community hospital, outpatient clinic, physical examination center and other places.

[0089] It should be noted that there can be one or more sample wells H105, as long as the blood sample can be diffused to each detection area through the diffusion layer 27. Preferably, there is one sample well H105, and the projection of the sample well H105 in the vertical direction covers at least part of the hemoglobin color development layer 20, the isolation layer 21, and at least part of the alanine aminotransferase color development layer 22. In this way, it is ensured that the required sample can be fully expanded to each color development layer.

[0090] In some embodiments of the present invention, the cartridge 10 is formed into a strip structure, and the hemoglobin color development layer 20 , the isolation layer 21 , the alanine aminotransferase color development layer 22 and the triglyceride color development layer 24 are sequentially arranged along the length direction of the cartridge 10 .

[0091] One end of the hemoglobin color development layer 20 adjacent to the isolation layer 21 and one end of the blood filtering layer 26 adjacent to the isolation layer 21 jointly cover the isolation layer 21 .

[0092] In this embodiment, the cartridge 10 is designed as a strip structure to facilitate subsequent operation and detection. The hemoglobin color development layer 20, the isolation layer 21, the alanine aminotransferase color development layer 22 and the triglyceride color development layer 24 are arranged in sequence along the length direction of the cartridge 10. This linear arrangement can make each detection area orderly distributed, avoid crosstalk, and ensure the accuracy of the test.

[0093] It should be noted that one end of the hemoglobin color development layer 20 and one end of the blood filter layer 26 are both adjacent to the isolation layer 21 and cover the isolation layer 21 together. This overlapping arrangement design allows the blood sample to diffuse from the sample loading hole H105 to the hemoglobin color development layer 20 and the blood filter layer 26 under the action of the expansion layer. At the same time, the excess blood can be absorbed at the isolation layer 21, and the remaining part can be further diffused to the alanine aminotransferase color development layer 22 and the triglyceride color development layer 24 after being filtered by the blood filter layer 26. The entire blood diffusion process is more orderly and reliable, and can absorb excess blood, ensuring that the diffusion of the blood sample can not only meet the needs of each detection area, but also avoid the problem of crosstalk between the reaction substances in different detection areas, further improving the independence and effectiveness of the detection of each detection area.

[0094] In some embodiments of the present invention, a support layer 28 is further included, the support layer 28 is located in the card shell 10, and the color development layer is arranged on the support layer 28. The support layer 28 is generally a plate-like member with a certain strength, which can provide a carrying support capability. There are four through holes H28 on the support layer 28, and the four through holes H28 correspond to the protein detection hole H101, the isolation detection hole H102, the enzyme detection hole H103 and the ester detection hole H104.

[0095] In this embodiment, the support layer 28 can play a good supporting role for the color development layer and other components. Four through holes H28 are opened on the support layer 28, and the positions of the four through holes H28 correspond to the protein detection hole H101, the isolation detection hole H102, the enzyme detection hole H103 and the ester detection hole H104 on the bottom surface of the card shell 10 respectively.

[0096] Such a structural design enables the photoelectric detection module to directly perform accurate photoelectric detection on the detection area corresponding to each color development layer through the detection hole at the bottom and the through hole H28 on the support layer 28 during testing. The support layer 28 provides a reliable carrier for the layer structure of the entire test card, ensuring the accuracy of the test process.

[0097] In some embodiments of the present invention, the isolation layer 21 includes an isolation upper layer 211 and an isolation lower layer 212 , wherein the isolation upper layer 211 is a blank mixed cellulose film, and the isolation lower layer 212 is a blank microporous nylon film.

[0098] The blank mixed cellulose membrane refers to a cellulose material without adding chemical components, which retains the excellent liquid absorption performance of cellulose itself. The blank mixed cellulose membrane can quickly absorb most of the water and some small molecules in the blood sample passing through, and the fiber structure can also efficiently intercept macromolecular components such as red blood cells and white blood cells. Therefore, the blank mixed cellulose membrane plays a role in preliminary separation and adsorption of blood components in the isolation layer 21.

[0099] The blank microporous nylon membrane at the bottom is a nylon material without any chemical ingredients added. Due to its microporous structure, it can further block the residual cell particles. The liquid absorption capacity of the blank microporous nylon membrane is poorer than that of the blank mixed cellulose membrane at the top, and it mainly plays the role of fine filtration and blocking.

[0100] In this embodiment, the double-layer membranes of the isolation upper layer 211 and the isolation lower layer 212 complement each other, the blank mixed cellulose membrane first absorbs most of the water and some small molecules, and the blank microporous nylon membrane further blocks the remaining cell impurities, so that the isolation layer 21 has the function of fully absorbing excess blood samples.

[0101] In some embodiments of the present invention, the hemoglobin color development layer 20 is a microporous nylon membrane pre-set with hemolytic substances and hemoglobin reactants. The microporous nylon membrane has a certain affinity and water retention, which is conducive to the color development reaction. When the blood sample diffuses into the hemoglobin color development layer 20, the hemolytic substances will dissolve the red blood cells to release hemoglobin, and then the hemoglobin will react with the pre-set reactants.

[0102] The alanine aminotransferase color development layer 22 is a microporous nylon membrane pre-set with alanine aminotransferase color development reactant, and the alanine aminotransferase auxiliary layer 23 is a mixed cellulose membrane pre-set with alanine aminotransferase reaction substrate. During the detection process, the alanine aminotransferase in the plasma first reacts with the substrate in the alanine aminotransferase auxiliary layer 23 to produce an intermediate product, and then diffuses to the alanine aminotransferase color development layer 22 to produce a color development reaction. The two-layer separation design can effectively avoid direct contact between the substrate and the color development reactant to cause non-specific reactions.

[0103] The triglyceride color development layer 24 is a microporous nylon membrane pre-set with a triglyceride color development reactant, and the triglyceride auxiliary layer 25 is a blank mixed cellulose membrane. That is, the triglyceride auxiliary layer 25 is a blank mixed cellulose membrane without any reactant pre-set. The plasma sample is initially separated and filtered through the triglyceride auxiliary layer 25, and then diffuses into the triglyceride color development layer 24 and undergoes a color development reaction.

[0104] In this embodiment, each color development layer uses a good microporous nylon membrane material and is pre-impregnated with the corresponding reactants. The auxiliary layer uses a mixed cellulose membrane, which has excellent liquid absorption and separation capabilities on the one hand, and can also be pre-impregnated with reagents such as reaction substrates on the other hand. The reasonable combination design of the color development layer and the auxiliary layer provides ideal reaction conditions for different detection items, thereby ensuring the accuracy of the test results.

[0105] Preferably, the blood filtering layer 26 is glass fiber pre-loaded with inorganic salts and sugar components. The diffusion layer 27 is a hydrophilic textile yarn, and the support layer 28 is a hard bottom plate.

[0106] Glass fiber itself has good mechanical strength and chemical stability, and the introduction of inorganic salts and sugars gives this layer excellent affinity and moisturizing properties. When a blood sample passes through this layer, macromolecules such as red blood cells are blocked, while plasma can be fully adsorbed and diffused.

[0107] The diffusion layer 27 is made of hydrophilic textile gauze material. The mesh structure of the gauze forms a porous diffusion channel, and the affinity of the material itself allows the plasma sample that has passed through the expansion layer to diffuse quickly and evenly along the preset path to the direction of each color development layer. The diffusion layer 27 achieves sample diversion to a certain extent, promoting the synchronous detection reaction.

[0108] The support layer 28 is made of a hard plate material, such as a hard bottom plate such as a plastic plate, a metal plate or a glass plate. The hard bottom plate can provide structural support for the entire test card to avoid misalignment caused by the deflection of the card body.

[0109] The rational selection of the above materials reflects the optimized design of each layer of the test card. The excellent separation performance of the glass fiber blood filter layer 26 of inorganic salts and sugars, the efficient diversion effect of the hydrophilic textile yarn diffusion layer 27, and the structural support capacity of the hard bottom support layer 28, the functional combination of the three ensures the high efficiency and reliability of sample processing and photoelectric detection, and provides a guarantee for the accuracy of the test results.

[0110] In one embodiment of the present invention, the amount of the hemolytic substance added is 5-40 g / L, and the amount of the hemoglobin reactant added is 1-30 g / L.

[0111] Hemolytic substances include surfactants, such as the cationic surfactant sodium dodecyl sulfate, which can effectively destroy the integrity of red blood cell membranes and promote the efficient release of hemoglobin.

[0112] The hemoglobin reactant is a substance that can combine with hemoglobin to form a derivative with stable light absorption characteristics, and the hemoglobin reactant is selected from one or more of potassium cyanide, potassium ferrocyanide, sodium azide, sodium nitrite, alkali hydroxyl, and sodium dodecyl sulfate. These substances can specifically combine with the heme group in hemoglobin to generate a compound with stable light absorption characteristics, showing a characteristic color corresponding to the hemoglobin content.

[0113] The added concentration of hemolytic substances and hemoglobin reactants must be controlled within the optimal range. Excessive amounts will result in excess substrate affecting the stability of the end point color, while too little will result in insufficient detection sensitivity. Only by accurately controlling the concentrations of the two can their effects be maximized to ensure the accuracy and reproducibility of hemoglobin detection. In this embodiment, the above concentration range is used to achieve highly sensitive and specific hemoglobin detection.

[0114] In one embodiment of the present invention, the alanine aminotransferase reaction substrate includes: 8-80 g / L L-alanine and 1-30 g / L α-ketoglutarate. When the alanine aminotransferase in plasma reacts with the two substrates, pyruvate and oxidoreductase are produced.

[0115] The alanine aminotransferase colorimetric reactant includes 5-50 g / L phosphate, 300-3000 u / L pyruvate oxidase, 800-8000 u / L catalase and 0.3-30 g / L colorimetric agent. The colorimetric agent includes aniline and imidazole. Phosphate maintains a suitable pH environment; catalase and pyruvate oxidase are two auxiliary enzymes that catalyze the generation of H2O2 and pyruvate, respectively.

[0116] There are many possibilities for the choice of color developer, including anilines such as palm red, p-aminophenol, etc., or imidazoles such as MBTH, etc.

[0117] In this example, selectivity examples of alanine aminotransferase reaction substrates and alanine aminotransferase colorimetric reactants are provided, and a suitable concentration range is given to achieve a balance between detection sensitivity and linear range. The appropriate ratio of the reactants not only ensures the efficient conduct of the reaction, but also ensures the accuracy and reliability of the detection results.

[0118] In one embodiment of the present invention, the triglyceride color development reactant includes 5-50 g / L phosphate, 800-80000 u / L lipoprotein lipase, 800-50000 u / L glycerol kinase, 800-50000 u / L glycerol-3-phosphate oxidase, 800-8000 u / L catalase and 0.3-30 g / L color developer. The color developer includes aniline and imidazole.

[0119] The phosphate solution maintains a suitable pH environment. Lipoprotein lipase hydrolyzes triglycerides into glycerol, glycerol kinase phosphorylates glycerol to produce glycerol-3-phosphate, and glycerol-3-phosphate oxidase oxidizes glycerol-3-phosphate to produce hydrogen peroxide. Finally, catalase catalyzes the color reaction of H2O2 with the color developer.

[0120] In one embodiment of the present invention, the addition amount of the inorganic salt is 2-20 g / L, the addition amount of the carbohydrate component is 10-100 g / L, the inorganic salt is selected from one or more of sodium chloride, potassium chloride, and sodium sulfate, and the carbohydrate component is selected from one or more of glucose, sucrose, lactose, and trehalose.

[0121] The role of inorganic salts is to maintain a suitable ionic strength and osmotic pressure environment, which is conducive to sample processing and reaction. The selection of inorganic salts includes sodium chloride, potassium chloride, sodium sulfate, etc. They can adjust the ionic strength and osmotic pressure of the solution medium to avoid swelling or rupture of cells.

[0122] The addition of sugar components is to enhance the affinity and moisture retention of the blood filter layer 26. Sugar molecules can form hydrogen bonds with glass fibers, giving the fibers hydrophilic and oleophobic properties, making them easier to adsorb plasma. At the same time, sugars can also regulate osmotic pressure and maintain the normal morphology of proteins and cells in plasma. Sugar components can be selected from common sugars such as glucose, sucrose, lactose, and trehalose.

[0123] The present invention also provides a method for preparing a dry chemical test card, comprising the following steps:

[0124] 1) Solution preparation: preparing a hemoglobin reactant solution, an alanine aminotransferase reaction substrate solution, an alanine aminotransferase colorimetric reactant solution, a triglyceride colorimetric reactant solution, and a blood filter layer 26 treatment solution;

[0125] 2) Membrane material immersion: The cut microporous nylon membrane is immersed in the prepared hemoglobin reactant solution, alanine aminotransferase colorimetric reactant solution and triglyceride colorimetric reaction solution respectively, and then placed in a 32 to 38°C environment for drying after standing for 5 to 15 minutes to obtain a hemoglobin colorimetric layer 20, an alanine aminotransferase colorimetric layer 22 and a triglyceride colorimetric layer 24.

[0126] The cut mixed cellulose membrane is placed in the prepared alanine aminotransferase reaction substrate solution, allowed to stand for 5 to 15 minutes, and then dried in an environment of 32 to 38°C to obtain the alanine aminotransferase auxiliary layer 23; the cut glass fiber membrane is placed in the prepared blood filter layer 26 treatment solution, allowed to stand for 5 to 15 minutes, and then dried in an environment of 32 to 38°C to obtain the blood filter layer 26.

[0127] 3) Assembly: sequentially attach the isolation lower layer 212, the alanine aminotransferase colorimetric layer 22, and the triglyceride colorimetric layer 24 to the support layer 28 with the adhesive tape; stack the alanine aminotransferase auxiliary layer 23 on the alanine aminotransferase colorimetric layer 22, stack the triglyceride auxiliary layer 25 on the triglyceride colorimetric layer 24, and stack the isolation upper layer 211 on the isolation lower layer 212; attach the hemoglobin colorimetric layer 20 to the support layer 28 and extend it to cover the isolation upper layer 211; stack the blood filter layer 26 on the isolation upper layer 211, the alanine aminotransferase auxiliary layer 23, and the triglyceride auxiliary layer 25, stack the diffusion layer 27 on the blood filter layer 26, and the diffusion layer 27 covers the hemoglobin colorimetric layer 20; load the stacked layer structure into the card shell 10 to form a dry chemical test card.

[0128] In one embodiment of the present invention, the preparation of the hemoglobin reaction solution, the alanine aminotransferase reaction substrate solution, the alanine aminotransferase color reaction solution, the triglyceride color reaction solution, and the blood filter layer 26 treatment solution comprises:

[0129] Dissolve 1-30 g / L of sodium dodecyl sulfate and 4-40 g / L of potassium ferrocyanide in deionized water, and stir evenly to obtain a hemoglobin reactant solution;

[0130] Dissolve 8 to 80 g / L of L-alanine and 1 to 30 g / L of α-ketoglutaric acid in deionized water, stir evenly, and obtain an alanine aminotransferase reaction substrate solution;

[0131] Dissolve 5-50 g / L of phosphate, 300-3000 u / L of pyruvate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain an alanine aminotransferase color reaction solution;

[0132] Dissolve 5-50 g / L of phosphate, 800-80000 u / L of lipoprotein lipase, 800-50000 u / L of glycerol kinase, 800-50000 u / L of glycerol-3-phosphate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain a triglyceride color development reaction solution;

[0133] 2-20 g / L of sodium chloride and 10-25 g / L of sucrose are dissolved in deionized water and stirred evenly to obtain a blood filter layer 26 treatment solution.

[0134] In one embodiment of the present invention, the preparation of the hemoglobin reaction solution, the alanine aminotransferase reaction substrate solution, the alanine aminotransferase color development reaction solution, and the blood filter layer 26 treatment solution comprises:

[0135] Dissolve 5-40 g / L of sodium deoxycholate and 1-30 g / L of sodium nitrite in deionized water, stir evenly, and obtain a hemoglobin reaction solution;

[0136] Dissolve 8 to 80 g / L of L-alanine and 1 to 30 g / L of α-ketoglutaric acid in deionized water, stir evenly, and obtain an alanine aminotransferase reaction substrate solution;

[0137] Dissolve 5-50 g / L of phosphate, 300-3000 u / L of pyruvate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain an alanine aminotransferase color reaction solution;

[0138] 2-20 g / L of sodium sulfate and 10-25 g / L of sucrose are dissolved in deionized water and stirred evenly to obtain a blood filter layer 26 treatment solution.

[0139] According to the preparation method provided by the embodiment of the present invention, a dry chemical test card can be produced, which is used to determine the content of hemoglobin, alanine aminotransferase, and triglycerides in human blood samples, so that hemoglobin, alanine aminotransferase, and triglycerides can be quickly determined simultaneously with one test card and one peripheral blood sampling. Each test item is independent of each other and does not interfere with each other, thereby improving the detection efficiency. The test card has the advantages of simple operation, low cost, no need for professional personnel to operate, no waste liquid treatment requirements, and rapid diagnosis during the detection process. It is equipped with a small detection instrument and can be moved at any time without being restricted by time and place. It can truly realize bedside diagnosis and is suitable for first aid, emergency, home, pharmacy, community hospital, outpatient clinic, physical examination center and other places.

[0140] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.

[0141] The above description is only a preferred embodiment of the present invention, and does not limit the patent scope of the present invention. All equivalent structural changes made by using the contents of the present invention specification and drawings under the inventive concept of the present invention, or directly / indirectly applied in other related technical fields are included in the patent protection scope of the present invention.

Claims

1. A dry chemical test card, It is characterized in that include: A card shell, wherein the top surface of the card shell is provided with a sample loading hole, and the bottom surface of the card shell is provided with a protein detection hole, an isolation detection hole, an enzyme detection hole and an ester detection hole; A color development layer is provided in the card shell, wherein the color development layer includes a hemoglobin color development layer, an isolation layer, an alanine aminotransferase color development layer and a triglyceride color development layer arranged in a horizontal direction, wherein the hemoglobin color development layer is in contact with the isolation layer, and the isolation layer and the alanine aminotransferase color development layer and the triglyceride color development layer are arranged at intervals from each other; the protein detection hole, the isolation detection hole, the enzyme detection hole and the ester detection hole correspond to the hemoglobin color development layer, the isolation layer, the alanine aminotransferase color development layer and the triglyceride color development layer one by one; An auxiliary layer is arranged in the card shell, the auxiliary layer includes an alanine aminotransferase auxiliary layer and a triglyceride auxiliary layer arranged in a horizontal direction, the alanine aminotransferase auxiliary layer is arranged above the alanine aminotransferase color development layer, and the triglyceride auxiliary layer is arranged above the triglyceride color development layer; A blood filtering layer is arranged in the card shell, the blood filtering layer is arranged above the auxiliary layer and covers the alanine aminotransferase auxiliary layer and the triglyceride auxiliary layer; A diffusion layer is arranged in the cartridge, the diffusion layer is arranged above the blood filter layer and covers the blood filter layer and the hemoglobin color development layer, and is used for diffusing the blood sample added to the sample adding hole to the blood filter layer and the hemoglobin color development layer; Among them, the hemoglobin color development layer is pre-set with hemolytic substances and hemoglobin reactants; the alanine aminotransferase color development layer is pre-set with alanine aminotransferase color development reactants, and the alanine aminotransferase auxiliary layer is pre-set with alanine aminotransferase reaction substrates; the triglyceride color development layer is pre-set with triglyceride color development reactants; the isolation layer is used to absorb excess blood sample to prevent the blood sample from diffusing into the alanine aminotransferase color development layer and the triglyceride color development layer.

2. The dry chemical test card according to claim 1, It is characterized in that The cartridge is formed into a strip structure, and the hemoglobin color development layer, the isolation layer, the alanine aminotransferase color development layer and the triglyceride color development layer are sequentially arranged along the length direction of the cartridge; One end of the hemoglobin color development layer adjacent to the isolation layer and one end of the blood filtering layer adjacent to the isolation layer jointly cover the isolation layer.

3. The dry chemical test card according to claim 1, It is characterized in that It also includes a support layer, which is located in the card shell, and the color development layer is arranged on the support layer; there are four through holes on the support layer, and the four through holes correspond to the protein detection hole, the isolation detection hole, the enzyme detection hole and the ester detection hole one by one.

4. The dry chemical test card according to claim 1, It is characterized in that The isolation layer comprises an isolation upper layer and an isolation lower layer, wherein the isolation upper layer is a blank mixed cellulose film, and the isolation lower layer is a blank microporous nylon film.

5. The dry chemical test card according to claim 3, It is characterized in that The hemoglobin color development layer is a microporous nylon membrane pre-set with hemolytic substances and hemoglobin reactants; The alanine aminotransferase color development layer is a microporous nylon membrane pre-set with an alanine aminotransferase color development reactant, and the alanine aminotransferase auxiliary layer is a mixed cellulose membrane pre-set with an alanine aminotransferase reaction substrate; The triglyceride color development layer is a microporous nylon membrane pre-set with a triglyceride color development reactant, and the triglyceride auxiliary layer is a blank mixed cellulose membrane. The blood filter layer is glass fiber pre-loaded with inorganic salts and sugar components; The diffusion layer is a hydrophilic textile mesh, and the support layer is a hard bottom plate.

6. The dry chemical test card according to claim 1, It is characterized in that The amount of the hemolytic substance added is 5 to 40 g / L, and the amount of the hemoglobin reactant added is 1 to 30 g / L; The hemolytic substance includes a surfactant, and the hemoglobin reactant is a substance that can combine with hemoglobin to form a derivative with stable light absorption characteristics. The hemoglobin reactant is selected from one or more of potassium cyanide, potassium ferrocyanide, sodium azide, sodium nitrite, alkali hydroxyl, and sodium dodecyl sulfate.

7. The dry chemical test card according to claim 1, It is characterized in that The alanine aminotransferase reaction substrate includes: 8-80 g / L L-alanine and 1-30 g / L α-ketoglutarate; The alanine aminotransferase color development reactant comprises 5-50 g / L phosphate, 300-3000 u / L pyruvate oxidase, 800-8000 u / L catalase and 0.3-30 g / L color developer.

8. The dry chemical test card according to claim 1, It is characterized in that The triglyceride color development reactant comprises 5-50 g / L phosphate, 800-80000 u / L lipoprotein lipase, 800-50000 u / L glycerol kinase, 800-50000 u / L glycerol-3-phosphate oxidase, 800-8000 u / L catalase and 0.3-30 g / L color developer.

9. The dry chemical test card according to claim 5, It is characterized in that The addition amount of the inorganic salt is 2-20 g / L, the addition amount of the carbohydrate component is 10-100 g / L, the inorganic salt is selected from one or more of sodium chloride, potassium chloride, and sodium sulfate, and the carbohydrate component is selected from one or more of glucose, sucrose, lactose, and trehalose.

10. A method for preparing a dry chemical test card, It is characterized in that The steps include: 1) Solution preparation: preparing a hemoglobin reactant solution, an alanine aminotransferase reaction substrate solution, an alanine aminotransferase colorimetric reactant solution, a triglyceride colorimetric reactant solution, and a blood filter layer treatment solution; 2) Membrane material immersion: The cut microporous nylon membrane is immersed in the prepared hemoglobin reactant solution, alanine aminotransferase colorimetric reactant solution and triglyceride colorimetric reaction solution respectively, and then placed in an environment of 32 to 38° C. for drying after standing for 5 to 15 minutes to obtain a hemoglobin colorimetric layer, an alanine aminotransferase colorimetric layer and a triglyceride colorimetric layer; The cut mixed cellulose membrane is placed in the prepared alanine aminotransferase reaction substrate solution, and after standing for 5 to 15 minutes, it is placed in an environment of 32 to 38° C. and dried to obtain an alanine aminotransferase auxiliary layer; the cut glass fiber membrane is placed in the prepared blood filter layer treatment solution, and after standing for 5 to 15 minutes, it is placed in an environment of 32 to 38° C. and dried to obtain a blood filter layer; 3) Assembly: sequentially attach the isolation lower layer, alanine aminotransferase colorimetric layer, and triglyceride colorimetric layer to the support layer with the adhesive tape; stack the alanine aminotransferase auxiliary layer on the alanine aminotransferase colorimetric layer, stack the triglyceride auxiliary layer on the triglyceride colorimetric layer, and stack the isolation upper layer on the isolation lower layer; attach the hemoglobin colorimetric layer to the support layer and extend it to cover the isolation upper layer; stack the blood filter layer on the isolation upper layer, the alanine aminotransferase auxiliary layer, and the triglyceride auxiliary layer, stack the diffusion layer on the blood filter layer, and the diffusion layer covers the hemoglobin colorimetric layer; load the stacked layer structure into a card shell to form a dry chemical test card.

11. The method for preparing the dry chemical test card according to claim 10, It is characterized in that The preparation of hemoglobin reaction solution, alanine aminotransferase reaction substrate solution, alanine aminotransferase color reaction solution, triglyceride color reaction solution, and blood filter layer treatment solution comprises: Dissolve 1-30 g / L of sodium dodecyl sulfate and 4-40 g / L of potassium ferrocyanide in deionized water, and stir evenly to obtain a hemoglobin reactant solution; Dissolve 8 to 80 g / L of L-alanine and 1 to 30 g / L of α-ketoglutaric acid in deionized water, stir evenly, and obtain an alanine aminotransferase reaction substrate solution; Dissolve 5-50 g / L of phosphate, 300-3000 u / L of pyruvate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain an alanine aminotransferase color reaction solution; Dissolve 5-50 g / L of phosphate, 800-80000 u / L of lipoprotein lipase, 800-50000 u / L of glycerol kinase, 800-50000 u / L of glycerol-3-phosphate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain a triglyceride color development reaction solution; Dissolve 2-20 g / L of sodium chloride and 10-25 g / L of sucrose in deionized water, stir evenly, and obtain a blood filter layer treatment solution.

12. The method for preparing the dry chemical test card according to claim 10, It is characterized in that The preparation of hemoglobin reaction solution, alanine aminotransferase reaction substrate solution, alanine aminotransferase color reaction solution, and blood filter layer treatment solution comprises: Dissolve 5-40 g / L of sodium deoxycholate and 1-30 g / L of sodium nitrite in deionized water, stir evenly, and obtain a hemoglobin reaction solution; Dissolve 8 to 80 g / L of L-alanine and 1 to 30 g / L of α-ketoglutaric acid in deionized water, stir evenly, and obtain an alanine aminotransferase reaction substrate solution; Dissolve 5-50 g / L of phosphate, 300-3000 u / L of pyruvate oxidase, 800-8000 u / L of catalase, and 0.3-30 g / L of imidazole in deionized water, stir evenly, and obtain an alanine aminotransferase color reaction solution; Dissolve 2-20 g / L of sodium sulfate and 10-25 g / L of sucrose in deionized water, stir evenly, and obtain a blood filter layer treatment solution.

Citation Information

Cited By

  • Test paper

    CN119355252A